Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Experimental Ophthalmology
>
2014
>
32
>
1
Volume:
32
Issue:
1
1. Repeatability and reproducibility of macular thickness profiles of intra-retinal layers determined by an automated algorithm with RTVue100 OCT
Page:51—55
2. Clinical effectiveness analysis of anti-VEGF for central retinal vein occlusion associated with macular edema : A Meta-analysis
Page:56—61
3. Comparison of clinical efficacy between bevacizumab combined with triamcinolne acetonide and versus bevacizumab via intraovitreal injection for diabetic macular edema: A Meta-analysis
Page:62—67
4. Research progress of application for gene chips in ophthalmology
Page:84—87
5. The causative factors and treatment of RPE cell-related eye diseases
Page:88—93
6. Diabetic retinopathy: a nonresolving inflammation
Page:94—96
7. Pay attention to the research work of stem cells transplantation for retinal diseases
Page:1—5
8. Modulation of PDGF on the expression of MMP-2,MMP-9 and TIMP-1 in human RPE cells
Page:6—11
9. The distribution and degeneration pattern of the cone opsins in rd11 mice
Page:12—17
10. Selective culture of rat retinal microvascular pericytes
Page:18—22
11. Changes of NADPH oxidase expression in retina of rd mice
Page:23—27
12. Effects of hypoxia on production of ATP and expression of mitochrome C in human meningothelial cells as the cerebral fluid-optic nerve barrier
Page:28—31
13. Selection of two types of rat strains for easily diabetic retinopathy
Page:32—35
14. The effect of bone marrow mesenchymal stem cells transplantation on the expressions of retinal Fas/FasL and caspase-3 after ichemic reperfusion injury
Page:36—40
15. Distribution of peroxisome proliferator-activated receptor γ in ocular tissues of rodent animal
Page:41—45
16. Protection of ischemic postconditioning from retinal ischeima reperfusion injury in rat
Page:46—50
17. db/db mouse and diabetic retinopathy
Page:75—79
18. Current approach to management of indirect traumatic optic neuropathy by glucocorticosteroid
Page:80—83